[
    [
        {
            "time": "",
            "original_text": "行业动态|医美再生材料大风起 业内研发人士：当前仍是透明质酸钠天下",
            "features": {
                "keywords": [
                    "医美",
                    "再生材料",
                    "透明质酸钠"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医美",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "行业动态|医美再生材料大风起 业内研发人士：当前仍是透明质酸钠天下",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "21深度丨200亿元中成药跨省联盟集采“官宣”，或将淘汰一半参与企业，20多家上市公司态度如何？",
            "features": {
                "keywords": [
                    "中成药",
                    "集采",
                    "上市公司"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "21深度丨200亿元中成药跨省联盟集采“官宣”，或将淘汰一半参与企业，20多家上市公司态度如何？",
                "Correlation": 5,
                "Sentiment": 4,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 6,
                "Market_Scope": 10,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "华东医药“母子对簿公堂”新进展：华东宁波拟年底法定清算 诉讼纠纷",
            "features": {
                "keywords": [
                    "华东医药",
                    "华东宁波",
                    "清算",
                    "诉讼"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "华东医药“母子对簿公堂”新进展：华东宁波拟年底法定清算 诉讼纠纷",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "华东医药对华东宁波管理未失去控制 将妥善做好后续清算工作",
            "features": {
                "keywords": [
                    "华东医药",
                    "华东宁波",
                    "清算",
                    "管理"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华东医药对华东宁波管理未失去控制 将妥善做好后续清算工作",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "华东医药回应子公司诉讼事件：计划年底清算华东宁波 坚持高端医美全球化战略布局 诉讼纠纷",
            "features": {
                "keywords": [
                    "华东医药",
                    "华东宁波",
                    "诉讼",
                    "医美",
                    "全球化战略"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "医美"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华东医药回应子公司诉讼事件：计划年底清算华东宁波 坚持高端医美全球化战略布局 诉讼纠纷",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "A股异动 | 华东医药(000963.SZ)涨9% 子公司英国Sinclair与KioMed签署独家许可协议",
            "features": {
                "keywords": [
                    "华东医药",
                    "Sinclair",
                    "KioMed",
                    "独家许可协议"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "国际合作"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "A股异动 | 华东医药(000963.SZ)涨9% 子公司英国Sinclair与KioMed签署独家许可协议",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 10,
                "Headline_Structure": 9,
                "Source_Recency": 10
            }
        }
    ]
]